Eli Lilly (LLY) Non-cash Items (2011)

Eli Lilly (LLY) posted Non-cash Items of $1.2 million for Q4 2011.

Eli Lilly (LLY) Non-cash Items (2011) Analysis & Trends

Eli Lilly (LLY) has reported Non-cash Items for 1 consecutive years, with $1.2 million the latest figure, recorded in Q4 2011.

Non-cash Items for Q4 2011 came in at $1.2 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2011 was $1.2 million (changed N/A YoY), and the FY2011 annual result was $1.2 million, changed N/A from the prior year.
Non-cash Items was $1.2 million for Q4 2011 at Eli Lilly.
Over five years, Non-cash Items peaked at $1.2 million in Q4 2011 and troughed at $1.2 million in Q4 2011.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Biogen	30.87 Bn	26.59 Bn	1.82 Bn

Historic Data

Download Data

Date	Value
Dec 31, 2011	1.20 Mn
Dec 31, 2011	1.20 Mn